24709919|t|Effects of ginsenosides on opioid-induced hyperalgesia in mice.
24709919|a|Opioid-induced hyperalgesia (OIH) is characterized by nociceptive sensitization caused by the cessation of chronic opioid use. OIH can limit the clinical use of opioid analgesics and complicate withdrawal from opioid addiction. In this study, we investigated the effects of Re, Rg1, and Rb1 ginsenosides, the bioactive components of ginseng, on OIH. OIH was achieved in mice after subcutaneous administration of morphine for 7 consecutive days three times per day. During withdrawal (days 8 and 9), these mice were administered Re, Rg1, or Rb1 intragastrically two times per day. On the test day (day 10), mice were subjected to the thermal sensitivity test and the acetic acid-induced writhing test. Re (300 mg/kg) inhibited OIH in both the thermal sensitivity test and the acetic acid-induced writhing test. However, the Rg1 and Rb1 ginsenosides failed to prevent OIH in either test. Furthermore, Rg1 showed a tendency to aggravate OIH in the acetic acid-induced writhing test. Our data suggested that the ginsenoside Re, but not Rg1 or Rb1, may contribute toward reversal of OIH.
24709919	11	23	ginsenosides	ChemicalEntity	D036145
24709919	27	33	opioid	ChemicalEntity	D000701
24709919	42	54	hyperalgesia	DiseaseOrPhenotypicFeature	D006930
24709919	58	62	mice	OrganismTaxon	10090
24709919	64	70	Opioid	ChemicalEntity	D000701
24709919	79	91	hyperalgesia	DiseaseOrPhenotypicFeature	D006930
24709919	93	96	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	179	185	opioid	ChemicalEntity	D000701
24709919	191	194	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	225	231	opioid	ChemicalEntity	D000701
24709919	274	290	opioid addiction	DiseaseOrPhenotypicFeature	D009293
24709919	338	367	Re, Rg1, and Rb1 ginsenosides	ChemicalEntity	C035054,C049864,C442759
24709919	397	404	ginseng	OrganismTaxon	4054
24709919	409	412	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	414	417	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	434	438	mice	OrganismTaxon	10090
24709919	476	484	morphine	ChemicalEntity	D009020
24709919	569	573	mice	OrganismTaxon	10090
24709919	592	594	Re	ChemicalEntity	C049864
24709919	596	599	Rg1	ChemicalEntity	C035054
24709919	604	607	Rb1	ChemicalEntity	C442759
24709919	670	674	mice	OrganismTaxon	10090
24709919	730	741	acetic acid	ChemicalEntity	D019342
24709919	765	767	Re	ChemicalEntity	C049864
24709919	790	793	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	839	850	acetic acid	ChemicalEntity	D019342
24709919	887	911	Rg1 and Rb1 ginsenosides	ChemicalEntity	C035054,C442759
24709919	930	933	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	963	966	Rg1	ChemicalEntity	C035054
24709919	998	1001	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	1009	1020	acetic acid	ChemicalEntity	D019342
24709919	1072	1086	ginsenoside Re	ChemicalEntity	C049864
24709919	1096	1099	Rg1	ChemicalEntity	C035054
24709919	1103	1106	Rb1	ChemicalEntity	C442759
24709919	1142	1145	OIH	DiseaseOrPhenotypicFeature	D006930
24709919	Negative_Correlation	C049864	D000701	Novel
24709919	Negative_Correlation	C049864	D006930	Novel
24709919	Positive_Correlation	C035054	D006930	Novel
24709919	Positive_Correlation	D000701	D006930	No
24709919	Association	D036145	D000701	Novel
24709919	Association	D036145	D006930	Novel